As of 2025-09-16, the Fair Value of Guardant Health Inc (GH) is -16.59 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 54.79 USD, the upside of Guardant Health Inc is -130.28%.
With the market price of 54.79 USD and our fair value calculation, Guardant Health Inc (GH) is not a good investment. Investing in GH stocks now will result in a potential loss of 130.28%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -253.80 | -405.70 | -654.60 | -479.45 | -436.37 | -445.98 |
| YoY growth | -235.27% | -59.85% | -61.35% | 26.76% | 8.98% | -64.15% |
| Market Cap (mil) | 6,832.86 |
| P/E | |
| Forward P/E |
| EPS | -3.32 |
| Avg earnings growth rate | -64.15% |
| TTM earnings | -413.82 |